Colossal Biosciences
A Texas-based biotechnology company pursuing genetic de-extinction projects, including the thylacine, woolly mammoth, dodo, and dire wolf.
This is a knowledge-graph entry: what our data records about Colossal Biosciences and how it connects to the rest of the atlas. It does not have a full article of its own yet.
Connected to
How this topic links to the people, places, and ideas around it — drawn from our knowledge graph.
Theories & Explanations
Colossal Biosciences operated Dire Wolf De-Extinction Claim.
People
Colossal Biosciences had as a member Beth Shapiro.
Places
Colossal Biosciences is located in United States.
Creatures & Figures
Colossal Biosciences investigated Thylacine — Colossal Biosciences is pursuing a genetic de-extinction programme for the species rather than searching for wild survivors.
Colossal Biosciences investigated Dire Wolf — Colossal's 2025 gene-editing programme worked from grey-wolf cells edited toward dire-wolf traits, not a search for surviving animals.
Explored on these pages
Did Scientists Really Bring Back the Dire Wolf?
Colossal Biosciences says it de-extincted the dire wolf in April 2025. Paleogeneticists disagree. Here's what the pups actually are, genetically.
Is the Tasmanian Tiger Really Extinct?
Is the Tasmanian tiger really extinct? The 1936 last captive death, the 2017 and 2023 statistical models, and Colossal Biosciences' de-extinction project.